Business

NHI Announces First Quarter 2025 Results

MURFREESBORO, TN / ACCESS Newswire / May 5, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months ended March 31, 2025. Financial Results and Recent Events Net income attributable to common stockholders ...

articleNational Health Investors, Inc.May 5, 202520/company/national-health-investors-inc/news/nhi-announces-first-quarter-2025-200500020
NHI Announces First Quarter 2025 Results

About this update from National Health Investors, Inc.

[{"type":"text","content":"MURFREESBORO, TN / ACCESS Newswire / May 5, 2025 / National Health Investors, Inc. (NYSE:NHI) announced today its results for the three months ended March 31, 2025.","length":164,"tagName":"p"},{"type":"text","content":"Financial Results and Recent Events","length":35,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Net income attributable to common stockholders per diluted common share for the three months ended March 31, 2025 was $0.74 compared to $0.71 during the same period in the prior year. Net income attributable to common stockholders for the three months ended March 31, 2025 includes approximately $0.3 million in proxy contest and related expenses for a proxy campaign associated with the Company's 2025 annual stockholders meeting and approximately $1.2 million in transaction costs described in greater detail below.","length":521,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":521,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"National Association of Real Estate Investment Trusts ("NAREIT") FFO per diluted common share was $1.14 for the three months ended March 31, 2025 compared to $1.10 during the same period in the prior year. NAREIT FFO for the three months ended March 31, 2025 includes approximately $0.3 million in proxy contest and related expenses and approximately $1.2 million in transaction costs.","length":395,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":395,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Normalized FFO per diluted common share for the three months ended March 31, 2025 was $1.15 compared to $1.12 during the same period in the prior year. Normalized FFO for the three months ended March 31, 2025 includes approximately $1.2 million in transaction costs.","length":266,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":266,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Normalized FAD for the three months ended March 31, 2025 was $56.0 million compared to $51.0 million during the same period in the prior year.","length":142,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":142,"olType":false},{"type":"list","items":[{"val":[{"type":"text","content":"Net income attributable to common stockholders, NAREIT FFO, Normalized FFO and Norma...

More updates from National Health Investors, Inc.

transaction costsNet income attributableThe CompanyNet operating incomeNormalized FADFFOcommon shareCompanyNAREITreal estate